Antibiotic restriction does not alter endemic colonization with resistant Gram-negative rods in a pediatric intensive care unit

被引:48
作者
Toltzis, P
Yamashita, T
Vilt, L
Green, M
Morrissey, A
Spinner-Block, S
Blumer, J
机构
[1] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[4] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA
关键词
antibiotic resistance; ceftazidime; Gram-negative aerobic bacteria; disease transmission; nosocomial infections; aminoglycoside; pediatric intensive care unit; field inversion electrophoresis; drug monitoring; drug effects;
D O I
10.1097/00003246-199811000-00035
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To test whether a ceftazidime restriction policy in a pediatric intensive care unit (ICU) could decrease the endemic rate of colonization with ceftazidime-resistant Gram-negative bacilli. Design: Prospective, pre- vs, postintervention study. Setting: University hospital pediatric ICU. Patients: Consecutive children admitted to the pediatric ICU over a 19-mo period. Interventions: After an observation period in which antibiotic use was not controlled, ceftazidime was prohibited unless the patient's microbiological results indicated that the drug was necessary for cure. Aminoglycoside use was not regulated. The size of the endemic reservoir of ceftazidime- and tobramycin-resistant organisms was determined by daily nasopharyngeal and rectal swab specimens obtained on all admissions to the ICU. Measurements and Main Results: Despite a 96% reduction in ceftazidime use, the incidence density (number of isolates/100 patient-days) of ceftazidime-resistant organisms increased through the course of the study, from 1,57 to 2.16, The incidence density of tobramycin-resistant organisms was unchanged. Ceftazidime restriction resulted in a small but nonsignificant decrease in the proportion of ceftazidime-resistant organisms acquired late (beyond 72 hrs) in the patients' ICU course (56.5% vs. 45.9%), However, there was a more substantial decrease in the proportion of ceftazidime-resistant organisms derived from species known to harbor derepressible amp C beta-lactamases (68.2% vs. 45.9%, p < .05). Conclusions: These data indicate that antibiotic restriction policies in an ICU fail to diminish the size of the endemic reservoir of antibiotic-resistant Gram-negative rods, and suggest that such policies in the absence of broader efforts to limit antibiotic use will have little impact.
引用
收藏
页码:1893 / 1899
页数:7
相关论文
共 42 条
[31]   Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy [J].
Rice, LB ;
Carias, LL ;
Bonomo, RA ;
Shlaes, DM .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (01) :151-158
[32]   Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center [J].
Rice, LB ;
Eckstein, EC ;
DeVente, J ;
Shlaes, DM .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (01) :118-124
[33]   TYPE-I BETA-LACTAMASES OF GRAM-NEGATIVE BACTERIA - INTERACTIONS WITH BETA-LACTAM ANTIBIOTICS [J].
SANDERS, CC ;
SANDERS, WE .
JOURNAL OF INFECTIOUS DISEASES, 1986, 154 (05) :792-800
[34]   MICROBIAL RESISTANCE TO NEWER GENERATION BETA-LACTAM ANTIBIOTICS - CLINICAL AND LABORATORY IMPLICATIONS [J].
SANDERS, CC ;
SANDERS, WE .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :399-406
[35]  
SHAH PM, 1991, SCAND J INFECT DIS, P22
[36]   RESISTANCE TO CEFOTAXIME AND 7 OTHER BETA-LACTAMS IN MEMBERS OF THE FAMILY ENTEROBACTERIACEAE - A 3-YEAR SURVEY IN FRANCE [J].
SIROT, DL ;
GOLDSTEIN, FW ;
SOUSSY, CJ ;
COURTIEU, AL ;
HUSSON, MO ;
LEMOZY, J ;
MEYRAN, M ;
MOREL, C ;
PEREZ, R ;
QUENTINNOURY, C ;
REVERDY, ME ;
SCHEFTEL, JM ;
ROSEMBAUM, M ;
REZVANI, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1677-1681
[37]   HOSPITAL-ACQUIRED INFECTIONS - DISEASES WITH INCREASINGLY LIMITED THERAPIES [J].
SWARTZ, MN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2420-2427
[38]   INTERPRETING CHROMOSOMAL DNA RESTRICTION PATTERNS PRODUCED BY PULSED-FIELD GEL-ELECTROPHORESIS - CRITERIA FOR BACTERIAL STRAIN TYPING [J].
TENOVER, FC ;
ARBEIT, RD ;
GOERING, RV ;
MICKELSEN, PA ;
MURRAY, BE ;
PERSING, DH ;
SWAMINATHAN, B .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (09) :2233-2239
[39]   Colonization with antibiotic-resistant Gram-negative organisms in a pediatric intensive care unit [J].
Toltzis, P ;
Yamashita, T ;
Vilt, L ;
Blumer, JL .
CRITICAL CARE MEDICINE, 1997, 25 (03) :538-544
[40]   PIPERACILLIN TAZOBACTAM COMPARED WITH CO-AMOXICLAV, AMPICILLIN PLUS SULBACTAM AND TIMENTIN AGAINST BETA-LACTAMASE-PRODUCING CLINICAL ISOLATES OF ESCHERICHIA-COLI, KLEBSIELLA-PNEUMONIAE AND KLEBSIELLA-OXYTOCA [J].
TRAUB, WH ;
LEONHARD, B .
CHEMOTHERAPY, 1995, 41 (05) :345-352